Alnylam 制药 ALNY
$155.94 −$0.72 (-0.46%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $155.42 -0.33%
开盘$155.22
昨收$156.66
当日区间$154.30 – $159.45
成交量2.83M
市值$20.89B
市盈率（TTM）8.1
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$1.29B+66.9% YoY
营业利润$231.44M+1,528.7% YoY
净利润$164.49M+327.7% YoY
摊薄每股收益$1.21+320.0% YoY
自由现金流$292.04M+152.8% YoY
经营现金流$326.72M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
毛利率79.7%
营业利润率20.8%
净利率16.1%
净资产收益率96.6%
资产收益率15.3%
投入资本回报率42.2%
流动比率3.05
负债/资产比率75.6%
现金及投资$3.31B
总负债$1.22B
净现金（净负债）$2.09B
自由现金流/营收17.1%
营收构成
2026/Q2 季度
按业务线
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 报告营业总收入 | $1.29B | $1.17B | $3.71B | $1.10B | $1.25B |
| 营业总收入 | $1.29B | $1.17B | $3.71B | $1.10B | $1.25B |
| 营业成本 | $298.45M | $211.12M | $681.87M | $267.72M | $200.15M |
| 毛利润 | $992.50M | $956.05M | $3.03B | $829.31M | $1.05B |
| 营业费用 | $761.06M | $687.42M | $2.53B | $697.59M | $680.89M |
| 销售及管理费用 | $347.92M | $322.55M | $1.21B | $325.37M | $322.08M |
| -管理费用 | $347.92M | $322.55M | $1.21B | $325.37M | $322.08M |
| 研发费用 | $413.13M | $364.87M | $1.32B | $372.22M | $358.81M |
| 营业利润 | $231.44M | $268.64M | $501.58M | $131.72M | $367.98M |
| 非经营性利息净收入（支出） | -$53.91M | -$42.69M | -$141.16M | -$102.71M | -$15.72M |
| 非经营性利息收入 | $28.14M | $26.60M | $111.47M | $26.63M | $28.68M |
| 非经营性利息支出 | $82.05M | $69.29M | $252.63M | $129.34M | $44.40M |
| 其他收入（支出） | $273,000.00 | -$4.30M | -$37.27M | $132.13M | -$113.30M |
| 其他非经营性收入（支出） | $273,000.00 | -$4.30M | $7.51M | -$3.36M | -$9.49M |
| 税前利润 | $177.81M | $221.65M | $323.15M | $161.14M | $238.97M |
| 税费 | $13.31M | $15.66M | $9.41M | -$25.28M | -$12.12M |
| 净利润 | $164.49M | $205.99M | $313.75M | $186.42M | $251.08M |
| 持续经营利润 | $164.49M | $205.99M | $313.75M | $186.42M | $251.08M |
| 归属母公司净利润 | $164.49M | $205.99M | $313.75M | $186.42M | $251.08M |
| 归属普通股股东净利润 | $164.49M | $205.99M | $313.75M | $186.42M | $251.08M |
| 基本每股收益 | $1.23 | $1.55 | $2.39 | $0.84 | $1.91 |
| 摊薄每股收益 | $1.21 | $1.51 | $2.33 | $0.82 | $1.84 |
| 证券出售收益 | – | – | -$2.31M | $138.81M | -$64.66M |
| 特殊收益（费用） | – | – | -$42.47M | -$3.33M | -$39.15M |
| -减：其他特殊支出 | – | – | $42.47M | $3.33M | $39.15M |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 总资产 | $5.56B | $5.13B | $4.97B | $4.97B | $4.85B |
| 流动资产合计 | $4.62B | $4.22B | $4.05B | $4.05B | $3.95B |
| 现金及现金等价物与短期投资 | $3.31B | $3.01B | $2.91B | $2.91B | $2.72B |
| -现金及现金等价物 | $1.71B | $1.71B | $1.66B | $1.66B | $1.49B |
| -短期投资 | $1.60B | $1.30B | $1.25B | $1.25B | $1.23B |
| 应收款 | $912.74M | $883.96M | $777.57M | $777.57M | $964.77M |
| -应收账款 | $912.74M | $883.96M | $777.57M | $777.57M | $964.77M |
| 存货 | $97.11M | $84.03M | $82.72M | $82.72M | $75.38M |
| 其他流动资产 | $302.18M | $242.10M | $281.89M | $281.89M | $188.04M |
| 非流动资产合计 | $938.60M | $910.24M | $915.67M | $915.67M | $898.85M |
| 固定资产净值 | $737.50M | $707.56M | $708.06M | $708.06M | $693.14M |
| -固定资产原值 | $737.50M | $707.56M | $1.03B | $1.03B | $693.14M |
| 一年以上递延资产 | $113.79M | $116.96M | $125.98M | $125.98M | $98.56M |
| 其他非流动资产 | $87.30M | $85.72M | $81.63M | $81.63M | $107.15M |
| 负债合计 | $4.20B | $4.05B | $4.18B | $4.18B | $4.62B |
| 流动负债合计 | $1.51B | $1.35B | $1.47B | $1.47B | $1.56B |
| 应付款 | $108.02M | $126.63M | $115.72M | $115.72M | $117.59M |
| -应付账款 | $108.02M | $126.63M | $115.72M | $115.72M | $117.59M |
| 一年内应计费用 | $1.10B | $946.49M | $823.00M | $823.00M | $1.15B |
| 短期债务及融资租赁负债 | $45.93M | $45.66M | $45.52M | $45.52M | $44.76M |
| -一年内到期融资租赁负债 | $45.93M | $45.66M | $45.52M | $45.52M | $44.76M |
| 一年内递延负债 | $4.01M | $3.21M | $4.85M | $4.85M | $2.54M |
| 其他流动负债 | $258.57M | $227.49M | $220.07M | $220.07M | $236.94M |
| 非流动负债合计 | $2.69B | $2.70B | $2.71B | $2.71B | $3.06B |
| 长期债务及融资租赁负债 | $1.22B | $1.23B | $1.23B | $1.23B | $1.26B |
| -长期债务 | $1.01B | $1.01B | $1.01B | $1.01B | $1.04B |
| -长期融资租赁负债 | $210.50M | $218.03M | $225.09M | $225.09M | $223.42M |
| 其他非流动负债 | $1.47B | $1.48B | $1.48B | $1.48B | $1.36B |
| 股东权益合计 | $1.35B | $1.08B | $789.18M | $789.18M | $233.89M |
| 股东权益 | $1.35B | $1.08B | $789.18M | $789.18M | $233.89M |
| 股本 | $1.34M | $1.33M | $1.32M | $1.32M | $1.32M |
| -普通股 | $1.34M | $1.33M | $1.32M | $1.32M | $1.32M |
| -优先股 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 资本公积 | $7.72B | $7.60B | $7.51B | $7.51B | $7.41B |
| 留存收益 | -$6.33B | -$6.50B | -$6.70B | -$6.70B | -$7.16B |
| 不影响留存收益的损益 | -$32.14M | -$24.89M | -$20.10M | -$20.10M | -$21.78M |
| -累计折旧 | – | – | -$322.70M | -$322.70M | – |
| 衍生产品负债 | – | – | $0.00 | $0.00 | $439.66M |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 经营活动现金流 | $326.72M | $70.50M | $524.08M | $163.56M | $351.03M |
| 持续经营经营活动现金流净额 | $326.72M | $70.50M | $524.08M | $163.56M | $351.03M |
| 持续经营净利润 | $164.49M | $205.99M | $313.75M | $186.42M | $217.81M |
| 折旧、折耗与摊销 | $13.90M | $13.55M | $55.66M | $13.51M | $13.80M |
| 递延税款 | $2.66M | $9.31M | -$2.20M | -$27.17M | $5.60M |
| 其他非现金项目 | $87.32M | $69.23M | $251.11M | $170.28M | $6.39M |
| 营运资金变动 | -$28.27M | -$297.73M | -$444.78M | -$73.15M | -$178.74M |
| -应收款变动 | -$31.60M | -$110.42M | -$359.96M | $184.25M | -$399.86M |
| -存货变动 | $280,000.00 | -$3.32M | $8.47M | -$13.86M | $4.98M |
| -预付资产变动 | -$59.37M | -$6.32M | -$117.72M | -$70.99M | -$20.74M |
| -应付账款及应计费用变动 | $61.62M | -$176.03M | $75.07M | -$174.85M | $249.43M |
| -其他营运资金变动 | $802,000.00 | -$1.63M | -$50.64M | $2.31M | -$12.54M |
| 投资活动现金流净额 | -$363.46M | -$25.54M | $436.33M | -$37.17M | $501.11M |
| 持续经营投资活动现金流净额 | -$363.46M | -$25.54M | $436.33M | -$37.17M | $501.11M |
| 固定资产购置及出售净额 | -$34.68M | -$21.83M | -$58.70M | -$23.29M | -$12.14M |
| 投资购置及出售净额 | -$302.88M | -$48.43M | $497.18M | -$13.87M | $515.40M |
| 其他投资变动净额 | -$25.90M | $44.73M | -$2.15M | $0.00 | – |
| 筹资活动现金流 | $36.24M | $15.71M | -$305.19M | $45.32M | -$474.27M |
| 持续经营筹资活动现金流净额 | $36.24M | $15.71M | -$305.19M | $45.32M | -$474.27M |
| 股票期权行使所得 | $33.56M | $13.16M | $250.03M | $41.70M | $77.74M |
| 其他筹资费用净额 | $2.68M | $2.56M | -$10.69M | $56.55M | -$60.41M |
| 期末现金余额 | $1.71B | $1.71B | $1.66B | $1.66B | $1.49B |
| 现金净变动 | -$496,000.00 | $60.68M | $655.22M | $171.71M | $377.87M |
| 期初现金余额 | $1.71B | $1.66B | $968.65M | $1.49B | $1.12B |
| 汇率变动影响 | -$2.45M | -$7.06M | $34.94M | -$5.70M | -$927,000.00 |
| 自由现金流 | $292.04M | $48.67M | $465.38M | $140.26M | $338.89M |
| 持续经营损益 | – | – | $2.31M | -$177.96M | $177.96M |
| 债务发行及偿还净额 | – | – | -$544.53M | -$52.93M | – |
暂无评论——快来第一个聊聊 ALNY。